Bio-Techne Corp (TECH)
77.29
+1.69
(+2.24%)
USD |
NASDAQ |
May 03, 16:00
77.31
+0.02
(+0.03%)
After-Hours: 20:00
Bio-Techne Cash from Financing (TTM): -86.52M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -86.52M |
| December 31, 2023 | 116.73M |
| September 30, 2023 | 125.93M |
| June 30, 2023 | 22.62M |
| March 31, 2023 | -18.89M |
| December 31, 2022 | -253.79M |
| September 30, 2022 | -234.98M |
| June 30, 2022 | -242.85M |
| March 31, 2022 | -59.44M |
| December 31, 2021 | -30.60M |
| September 30, 2021 | -67.30M |
| June 30, 2021 | -62.55M |
| March 31, 2021 | -224.96M |
| December 31, 2020 | -187.52M |
| September 30, 2020 | -194.47M |
| June 30, 2020 | -183.80M |
| March 31, 2020 | -158.98M |
| December 31, 2019 | -168.24M |
| September 30, 2019 | -112.42M |
| June 30, 2019 | 134.38M |
| March 31, 2019 | 91.45M |
| December 31, 2018 | 117.54M |
| September 30, 2018 | 174.30M |
| June 30, 2018 | -99.19M |
| March 31, 2018 | -53.00M |
| Date | Value |
|---|---|
| December 31, 2017 | -76.57M |
| September 30, 2017 | -104.00M |
| June 30, 2017 | 189.11M |
| March 31, 2017 | 173.42M |
| December 31, 2016 | 178.41M |
| September 30, 2016 | 176.93M |
| June 30, 2016 | -23.37M |
| March 31, 2016 | -76.71M |
| December 31, 2015 | -68.18M |
| September 30, 2015 | -29.33M |
| June 30, 2015 | 31.28M |
| March 31, 2015 | 108.94M |
| December 31, 2014 | 110.03M |
| September 30, 2014 | 75.57M |
| June 30, 2014 | -36.81M |
| March 31, 2014 | -41.38M |
| December 31, 2013 | -42.52M |
| September 30, 2013 | -43.83M |
| June 30, 2013 | -44.68M |
| March 31, 2013 | -44.54M |
| December 31, 2012 | -46.69M |
| September 30, 2012 | -53.82M |
| June 30, 2012 | -64.62M |
| March 31, 2012 | -60.42M |
| December 31, 2011 | -57.24M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-253.79M
Minimum
Dec 2022
134.38M
Maximum
Jun 2019
-94.38M
Average
-99.47M
Median
Cash from Financing (TTM) Benchmarks
| Agilent Technologies Inc | -1.153B |
| Bio-Rad Laboratories Inc | -425.65M |
| Revvity Inc | -868.95M |
| Twist Bioscience Corp | 0.136M |
| AIM ImmunoTech Inc | 0.485M |